Patient-level data meta-analysis of a multi-modal artificial intelligence (MMAI) prognostic biomarker in high-risk prostate cancer: results from six NRG/RTOG phase III randomized trials

Category Systematic review
JournalJournal of clinical oncology
Year 2023
This article has no abstract
Epistemonikos ID: 98e920dc1399de36b30c5da1e44a28fc86a1a1e7
First added on: Feb 15, 2025